Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axatilimab + ECP in Chronic Graft-versus-Host Disease
NCT06663722Phase 2Recruiting
- Sponsor
- University of Miami
- Start
- May 2025
- Primary completion
- May 2030
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of axatilimab in chronic graft-versus-host disease (cGVHD), sponsored by University of Miami. Started May 2025; status: recruiting.
02
Drugs
axatilimab
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT06663722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06663722.